CRYOPORT, INC. Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31)
CRYOPORT, INC. (CYRX) reported Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) of 10.00% for the 12-month period ending 2013-03-31, per its 10-K filed 2013-06-25.
Discontinued › Income Statement › Other Income
us-gaap:EntityWideRevenueMajorCustomerPercentage · last filed 2013-06-25
- CRYOPORT, INC. entity-wide revenue, major customer, percentage (deprecated 2013-01-31) for the quarter ending 2012-12-31 was 10.00%, a 54.55% decline year-over-year.
- CRYOPORT, INC. entity-wide revenue, major customer, percentage (deprecated 2013-01-31) for the quarter ending 2012-09-30 was 10.00%, a 67.74% decline year-over-year.
- CRYOPORT, INC. entity-wide revenue, major customer, percentage (deprecated 2013-01-31) for the quarter ending 2012-06-30 was 16.00%, a 23.81% decline year-over-year.
- CRYOPORT, INC. entity-wide revenue, major customer, percentage (deprecated 2013-01-31) for the quarter ending 2011-12-31 was 22.00%.
- CRYOPORT, INC. entity-wide revenue, major customer, percentage (deprecated 2013-01-31) for fiscal 2013 was 10.00%, a 61.54% decline from fiscal 2012.
- CRYOPORT, INC. entity-wide revenue, major customer, percentage (deprecated 2013-01-31) for fiscal 2012 was 26.00%.
| Period end | Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) 3 month | Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) 6 month | Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) 9 month | Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | 10.00% 10-K · filed 2013-06-25 | |||
| 2012-12-31 | 10.00% 10-Q · filed 2013-02-14 | 10.00% 10-Q · filed 2013-02-14 | ||
| 2012-09-30 | 10.00% 10-Q · filed 2012-11-09 | 11.00% 10-Q · filed 2012-11-09 | ||
| 2012-06-30 | 16.00% 10-Q · filed 2012-08-14 | |||
| 2012-03-31 | 26.00% 10-K · filed 2013-06-25 | |||
| 2011-12-31 | 22.00% 10-Q · filed 2013-02-14 | 27.00% 10-Q · filed 2013-02-14 | ||
| 2011-09-30 | 31.00% 10-Q · filed 2012-11-09 | 31.00% 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | 21.00% 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |